STRUCTURAL ELEMENTS PERTINENT TO THE INTERACTION OF CYCLOSPORINE-A WITH ITS SPECIFIC RECEPTOR PROTEIN, CYCLOPHILIN

被引:22
|
作者
HSU, VL
HEALD, SL
HARDING, MW
HANDSCHUMACHER, RE
ARMITAGE, IM
机构
[1] YALE UNIV,SCH MED,DEPT MOLEC CARCINOGENESIS,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT TRANSPLANTAT SURG,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT DIAGNOST RADIOL,NEW HAVEN,CT 06510
[4] MILES RES CTR,W HAVEN,CT 06516
关键词
D O I
10.1016/0006-2952(90)90188-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclophilin (163 amino acids; 17, 737 daltons) is a ubiquitous cytosolic protein that specifically binds the potent immunosuppressive drug cyclosporin A (CsA). To characterize the structural details of this interaction, extensive use has been made of two-dimensional (2D) NMR methods. For studies on CsA, these methods are being used to assign the conformational space accessible to CsA by analysis of the spectra from the multiple CsA conformers present in slow exchange in mixed solvent systems. These same 2D NMR methods also have been used for extensive studies of the major bovine thymus cyclophilin (CyP) isoform and its complex with stoichiometric amounts of CsA. In the former case, these studies have revealed 81% of the 156 expected hN-Hα crosspeaks. The complete spin-coupled spin systems for one-third of these amide resonances have been assigned according to amino acid type. After exhaustive D2O exchange, there remain 44 amide protons which exhibit 2D NMR features indicative of a hydrophobic domain with β-sheet secondary structure. The CsA-complexed form of CyP exhibits a discrete structure and set of resonances in slow exchange with the drug-free CyP. The amino acids that have been specifically identified to be affected by the interaction are limited in number and include three Phe residues, the unique Trp at position 120, and two Ala residues. © 1990.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 50 条
  • [31] H-1, C-13 AND N-15 BACKBONE ASSIGNMENTS OF CYCLOPHILIN WHEN BOUND TO CYCLOSPORINE-A (CSA) AND PRELIMINARY STRUCTURAL CHARACTERIZATION OF THE CSA BINDING-SITE
    NERI, P
    MEADOWS, R
    GEMMECKER, G
    OLEJNICZAK, E
    NETTESHEIM, D
    LOGAN, T
    SIMMER, R
    HELFRICH, R
    HOLZMAN, T
    SEVERIN, J
    FESIK, S
    FEBS LETTERS, 1991, 294 (1-2): : 81 - 88
  • [32] A NOVEL ORPHAN RECEPTOR-SPECIFIC FOR A SUBSET OF THYROID HORMONE-RESPONSIVE ELEMENTS AND ITS INTERACTION WITH THE RETINOID/THYROID HORMONE-RECEPTOR SUBFAMILY
    APFEL, R
    BENBROOK, D
    LERNHARDT, E
    ORTIZ, MA
    SALBERT, G
    PFAHL, M
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) : 7025 - 7035
  • [33] Congenital disease SNPs target lineage specific structural elements in protein kinases
    Torkamani, Ali
    Kannan, Natarajan
    Taylor, Susan S.
    Schork, Nicholas J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (26) : 9011 - 9016
  • [34] Structural basis for the interaction between pectin methylesterase and a specific inhibitor protein
    Di Matteo, A
    Giovane, A
    Raiola, A
    Camardella, L
    Bonivento, D
    De Lorenzo, G
    Cervone, F
    Bellincampi, D
    Tsernoglou, D
    PLANT CELL, 2005, 17 (03): : 849 - 858
  • [35] REVERSIBLE INTERACTION BETWEEN COLIPHAGE LAMBDA AND ITS RECEPTOR PROTEIN
    SCHWARTZ, M
    JOURNAL OF MOLECULAR BIOLOGY, 1975, 99 (01) : 185 - 201
  • [36] A STUDY OF THE SEQUENCE-SPECIFIC INTERACTION OF THE CAMP RECEPTOR PROTEIN WITH DNA
    GENT, ME
    GRONENBORN, AM
    DAVIES, RW
    CLORE, GM
    PROTEIN ENGINEERING, 1987, 1 (03): : 236 - 236
  • [37] EVIDENCE OF DRUG-INTERACTION BETWEEN CYCLOSPORINE-A AND H2-RECEPTOR ANTAGONISTS (CIMETIDINE, RANITIDINE AND FAMOTIDINE) IN SPRAGUE-DAWLEY RATS
    FILINGERI, V
    GIACOMELLI, R
    FAMULARO, G
    ROSATI, R
    NARDI, S
    CALOGERO, A
    IACONA, A
    STORTONI, F
    CRAMAROSSA, L
    SACCHETTI, S
    CERVELLI, V
    TONIETTI, G
    CASCIANI, CU
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1989, 15 (04) : 159 - 164
  • [38] Structural determinants of the interaction between Toxoplasma gondii cyclophilin and the HIV-1 co-receptor CCR5
    Yarovinsky, F
    Andersen, JF
    Khurana, S
    King, LR
    Aliberti, J
    Golding, H
    Sher, A
    FASEB JOURNAL, 2005, 19 (04): : A939 - A939
  • [39] Modulation by substrates of the interaction between the HasR outer membrane receptor and its specific TonB-like protein, HasB
    Lefevre, Julien
    Delepelaire, Philippe
    Delepierre, Muriel
    Izadi-Pruneyre, Nadia
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 378 (04) : 840 - 851
  • [40] INTERACTION OF AN OVARIAN-SPECIFIC PROTEIN WITH THE SHORT-FORM OF THE PROLACTIN RECEPTOR
    DUAN, WR
    FALISZEK, J
    LINZER, DIH
    GIBORI, G
    BIOLOGY OF REPRODUCTION, 1995, 52 : 145 - 145